Yatiri Bio completed the acquisition of NGeneBioAI.

Yatiri Bio, a provider of bio-medical data solutions, completed the acquisition of NGeneBioAI, a San Diego-based company specializing in plasma proteomics and AI-powered diagnostics. Financial terms were not disclosed. "NGeneBioAI has built a robust foundation in plasma-based diagnostics, with unique strengths in protein detection and applied machine learning. By integrating their technologies and CLIA- and CAP-certified laboratory infrastructure into our platform, we are positioned to advance the development of potentially clinically actionable biomarker signatures designed to inform both diagnostics and therapeutic innovation," Pilgrim Jackson, Yatiri Bio CEO & Co-Founder.